Genome Square
1 known investors
Genome Diagnostics develops blood-based liquid biopsy tests for cancer detection and monitoring, including a product for ovarian cancer recurrence detection and one for early pancreatic cancer detection. Its GenoME pipeline identifies DNA methylation and fragmentomic changes from liquid biopsy or tissue samples.
BiotechHealthtechMedical Devices